Nexus Global Group 1

CONNECTING SCIENCE AND PEOPLE

At Nexus Global Group, we bridge the gaps between biopharma innovators, healthcare providers (HCPs), and patients. With deep engagement within the medical community, actionable insights, and advanced analytics—including AI‑enabled solutions—we help leading biopharma companies connect across the healthcare ecosystem in ways that inspire trust, foster collaboration, and deliver results.

Rooted in high-science medical communications and a proven history of building meaningful relationships, we ensure your message resonates with the audiences who matter most. Our expertise spans oncology, hematology, cell therapy, rare diseases, metabolic disorders, immunology, and other pioneering areas, driving progress in some of the most critical fields in medicine.

Partner with Vaniam Group to amplify innovations, accelerate breakthroughs, and shape the future of healthcare.

What you can expect

Market Access and 
Insights

  • Third‑party programming for patients & healthcare providers
  • Market access and insights
  • Competitive Intelligence
  • Brand strategy development and media relations
  • Public relations campaigns and media relations
  • Stakeholder engagement programs
  • Patient engagement
  • Booth design
  • Launch readiness
  • Key Opinion Leader / Digital Opinion Leader playbook

Scientific Communications and Medical Engagement

  • Scientific content creation and medical writing
  • Scientific storytelling
  • Congress planning and scientific presentations
  • Publications support and manuscript development
  • Publication strategy
  • Abstracts & manuscripts
  • Medical information
  • Advisory board development and facilitation
  • Engaging HCPs and KOLs for clinical insights
  • Medical Science Liaison (MSL) tools

Brand Strategy and Scientific Engagement

  • Clinical development strategy
  • Trial acceleration
  • Asset prioritization
  • Pipeline marketing
  • Investigator profiling
  • Investigator meetings
  • Site training
  • Steering committees
  • Research forums
  • Field training

© 2026 Nexus Global Group Science, a Vaniam Group company